- By Shivam Shandilya
- Thu, 26 Sep 2024 09:53 PM (IST)
- Source:JND
Torrent, the pharmaceutical firm, refuted media reports of its product "Shelcal 500" being of nonstandard quality. It also added that the sample collected by the drug regulator CDSCO is not manufactured by the company and is in fact non-genuine and spurious.
Several recent articles, according to news agency UNI, have been issued in media with reference to the Central Drugs Standard Control Organization (CDSCO) East Zone, Kolkata report referring to one batch (GDXD0581) sample of Product Shelcal 500, amongst other drugs marketed by various pharmaceutical companies, allegedly being non-standard quality (NSQ).
According to the report, a comparative evaluation was carried out with our controlled sample of the same batch. This was done to verify the genuineness of the sample collected by CDSCO. The outcome of the analysis concluded that the sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious, the company said in a statement, reports news agency UNI.
Torren has implemented a QR code on Shelcal displaying batch manufacturing details to verify its authenticity, which was found to be lacking in the sample seized by CDSCO, the company claimed.
“Our assessment of establishing authenticity of samples including physical appearance, QR code and labelling text comparison establishes that the NSQ sample is non-genuine and counterfeit, whereas our controlled sample matches with pre-defined specifications,” it added.
Torrent has already submitted a formal response along with an assessment report, concluding the “seized sample as spurious” to CDSCO.
Each and every batch manufactured is also subjected to strict quality testing. We assure that all products manufactured and marketed by Torrent follow Good Manufacturing Practices (GMP) and are controlled through pre-established specifications and/or regulatory norms, it said.
(With input from agencies)
